Journal of Clinical Pathways June, 2020
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors, and beneficiaries. To get a clearer understanding of how payers are reacting to new benefit allowances, 25 Medicare plan sponsors were surveyed with responsibility for over 27 million Medicare Advantage prescription drug plan lives and over 24 million Medicare prescription drug plan lives. Based on history and how participants responded to the survey, benefit design changes are needed to address the shifts in drug utilization that have occurred since the early days of Part D.
Let us pretend for a moment that we are in a time machine and...
Today's Sponsors
Today's Sponsor